西藏药业 (600211)
Tibet Rhodiola Pharmaceutical Holding Co.
K-Line Chart
No K-line data available
Company NameTibet Rhodiola Pharmaceutical Holding Co., Ltd.
Listing Date1999-07-21
Issue Price6RMB
Registered Capital32231.919610k RMB
Legal RepresentativeChen Dabin
Registered AddressNo. 3 Guangzhou Road, Zone A, Lhasa Economic and Technological Development Zone, Tibet
IndustryBiological Products
Main BusinessProduction and sales of capsules, biological agents, granules, coating agents, etc.
Company ProfileTibet Rhodiola Pharmaceutical Holding Co., Ltd. is the first high-tech pharmaceutical listed enterprise in the Tibet Autonomous Region. Since 1999, the company has been continuously recognized as a high-tech enterprise and a leading agricultural and animal husbandry enterprise in the Tibet Autonomous Region. In 2001, it was recognized by the Ministry of Science and Technology as a National Torch Program Key High-tech Enterprise. In 2009, it was recognized as an Innovative Enterprise by the state. In 2010, the company was honored as a National Key Leading Enterprise in Agricultural Industrialization. The company's products, Rhodiola Capsules and Shiwei Dida Capsules, have been rated as National Protected Traditional Chinese Medicine Varieties. Furthermore, they have been classified as a Secret-level National Secret Technology by the National Administration of State Secrets Protection and the Ministry of Science and Technology.
Stock Details
1. Key Indicators
- Total Shares(W): 32231.92
- Circulating A-Shares(W): 32231.92
- Earnings Per Share(RMB): 2.2400
- Net Assets Per Share(RMB): 11.0184
- Operating Revenue(W RMB): 208927.09
- Total Profit(W RMB): 81045.39
- **Net Profit Attributable to Parent(W RMB) **: 72177.72
- Net Profit Growth Rate(%): -8.85
- Weighted Return on Equity(%): 17.8900
- Operating Cash Flow Per Share(RMB): 2.2120
- Undistributed Profit Per Share(RMB): 7.0900
- Capital Reserve Per Share(RMB): 2.2251
2. Main Business
The main business covers:
- Production and sales of capsules
- Production and sales of biological preparations
- Production and sales of granules, coating agents, etc.
3. Company Basic Information
- Company Name: Tibet Rhodiola Pharmaceutical Holding Company
- Listing Date: 1999-07-21
- Industry: Pharmaceutical Manufacturing
- Address: No. 93 Beijing Middle Road, Lhasa, Tibet Autonomous Region (Registered Address); No. 3 Guangzhou Road, Zone A, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region; No. 427 Sanse Road, Jinjiang District, Chengdu City, Sichuan Province (Office Address)
- Website: http://www.xzyy.cn
- Company Profile: The company was established on July 14, 1999, through a public offering, with Tibet Huaxi Pharmaceutical Group Co., Ltd. as the main sponsor, jointly initiated by four enterprises including Tibet Autonomous Region Tibetan Medicine Factory, Tibet Autonomous Region Science and Technology Development Exchange Center, Tibet Kelong Construction Building Materials Co., Ltd., and Tibet Keguang Solar Energy Engineering Technology Co., Ltd. The sponsors contributed part of their production and operating net assets and cash, converted into 77.60 million state-owned legal person shares. After issuing 45 million public shares on July 1, 1999, the company's total share capital reached 122.60 million shares. Its public shares were listed on the Shanghai Stock Exchange on July 21, 1999.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Tibet Kangzhe Enterprise Management Co., Ltd. | General Legal Person | 10404.34 | 32.28 |
| 2 | Tibet Huaxi Pharmaceutical Group Co., Ltd. | General Legal Person | 5614.83 | 17.42 |
| 3 | Beijing New Phoenix City Real Estate Development Co., Ltd. | General Legal Person | 1028.30 | 3.19 |
| 4 | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | General Legal Person | 1002.13 | 3.11 |
| 5 | Tianjin Kangzhe Pharmaceutical Technology Development Co., Ltd. | General Legal Person | 633.94 | 1.97 |
| 6 | Tibet Science and Technology Innovation Investment Co., Ltd. | General Legal Person | 619.90 | 1.92 |
| 7 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 365.85 | 1.14 |
| 8 | Guojin Securities (Hong Kong) Limited - Client Funds (Exchange) | General Legal Person | 240.89 | 0.75 |
| 9 | Yinhua CSI Innovative Drug Industry ETF | Fund | 158.17 | 0.49 |
| 10 | Southern CSI 1000 ETF | Fund | 147.59 | 0.46 |
5. Concept Sectors
- Biological Vaccines
- Infant and Child Concept
- Brain-Computer Interface
- Innovative Drugs
- Margin Trading & Securities Lending
- Blue-chip Stocks
- MSCI Constituent
- Restructuring Stocks
- High Dividend Stocks
- SSE 380
Remarks
- Data update date: 2025-11-02
- Data source: Public Market Information